Tag - Myomo

NEO has played critical role in success of Boston-based medical device maker

Ziad2022-11-25T14:05:41-05:00When Boston-based medical device company Myomo rang the bell of the New York Stock Exchange on June 16, it was doing more than heralding the company's first-of-its-kind, $5 million initial public offering of stock. Read more >>

Reg A+ Issuer MyomoTrades Up Following Listing on NYSE MKT

Ziad2022-11-25T14:05:41-05:00It has been one week since Myomo (NYSE:MYO) became the first Reg A+ issuer to successfully crowdfund and then list on NYSE MKT. But since listing on the public exchange, Myomo has moved in the right direction. Read more >>

Myomo, Inc. to Ring NYSE MKT Closing Bell Today

Ziad2022-11-25T14:05:41-05:00Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and CEO, Paul R. Gudonis, will ring today’s closing bell at the New York Stock Exchange (NYSE) MKT in New York City in commemoration of its initial public offering (IPO) closing on June 9, 2017. Read more >>

Salem stroke survivor rings stock exchange bell, thanks to new technology

Ziad2022-11-25T14:05:42-05:00Two partially paralyzed stroke survivors will ring the New York Stock Exchange closing bell Friday night with CEO Paul Gudonis in a symbolic gesture of the company's trade presence on Wall Street. Jessica Peters of Salem and JayJay Johnson of Ohio can ring the closing bell at 4 p.m. on the floor of the NYSE because they wear devices, produced by Myomo, that detect the weak muscle signals in their arms, which activate the devices' motors to move their arms in the desired...

Myomo, Inc. Launches MyoPro® 2

Ziad2022-11-25T14:05:42-05:00Myomo, Inc., a commercial stage medical robotics company, today announced the launch of its next-generation MyoPro® myoelectric arm orthosis (powered brace), the only lightweight wearable device that can restore function in the paralyzed or weakened arms and hands of individuals who have suffered a stroke, spinal cord or nerve injury, or other neuromuscular disability. Read more >>

Myomo, Inc. Presents at 2017 Marcum MicroCap Conference

Ziad2022-11-25T14:05:42-05:00Myomo, Inc., a commercial stage medical robotics company, today announced that its Chairman and CEO, Paul R. Gudonis, will be presenting at the 2017 Marcum MicroCap Conference at the Grand Hyatt Hotel in New York City. Read more >>

Myomo closes $5m IPO

Ziad2022-11-25T14:05:42-05:00Myomo said last week it closed its initial public offering, raising $5 million and listing on the New York Stock Exchange today under the ticker “MYO”. Read more >>

Is Reg A+ Crowdfunding Quickly Coming of Age?

Ziad2022-11-25T14:05:42-05:00Next week on June 12th, Myomo says it will list its shares on the NYSE MKT under the ticker symbol MYO. Myomo raised $7.9 million with $5 million coming from the “crowd” under Reg A+ and $2.9 million from a private sale of restricted securities to accredited investors – most of which were early investors in Myomo. Read more >>

Myomo, Inc. Completes Historic Initial Public Offering

Ziad2022-11-25T14:05:42-05:00Myomo, Inc., a commercial stage medical robotics company, today announced the completion of its initial public offering (IPO) under SEC Regulation A+, raising $5.0 Million through the sale of 665,498 shares of its common stock at a price to the public of $7.50 per share. Read more >>

Finish Line: Will Myomo Raise Enough Under Reg A+ to List on NYSE MKT?

Ziad2022-11-25T14:05:42-05:00We last wrote about Myomo, a commercial stage medical robots company (kind of like the Bionic Man), in March. Myomo was in the process of using Reg A+ to raise growth capital. Read more >>